Indeed, in patients with congenital generalised lipodystrophy, leptin treatment, which is known to improve metabolic complications including insulin resistance, has been recently shown to attenuate cardiac hypertrophy and increase contractile function.42 This evidence concerns the gene LEP and Insulin resistance.